ZIOPHARM ONCOLOGY INC·4

May 6, 7:26 PM ET

Vieser Jaime 4

4 · ZIOPHARM ONCOLOGY INC · Filed May 6, 2021

Insider Transaction Report

Form 4
Period: 2021-03-04
Vieser Jaime
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-03-04+31,25031,250 total
    Exercise: $4.31Exp: 2031-03-03Common Stock (31,250 underlying)
  • Award

    Common Stock

    2021-03-04+4,167605,321 total
  • Award

    Stock Option (right to buy)

    2021-03-04+150,000150,000 total
    Exercise: $4.31Exp: 2031-03-03Common Stock (150,000 underlying)
Holdings
  • Common Stock

    (indirect: By Children)
    100,000
  • Common Stock

    (indirect: By Children)
    75,000
  • Common Stock

    (indirect: By Children)
    75,000
  • Common Stock

    (indirect: By Children)
    75,000
Footnotes (3)
  • [F1]The shares will vest on 5/19/2021.
  • [F2]1/3rd of the shares underlying this option will vest on 4/4/2021, 5/4/2021 and 5/19/2021.
  • [F3]1/36th of the shares underlying this option will vest in equal monthly installments commencing one month after 12/15/2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION